Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer
Clinical trial NCT02643667 · COMPLETED
Trial details
- NCT number
- NCT02643667
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2023-04-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.